Author

Daowei Huang

Observed name: Huang, Daowei

Institutions: University of North Carolina at Chapel Hill, Hebei University of Science and Technology

Observed institutions: University of North Carolina at Chapel Hill, Hebei University of Science and Technology

ORCID: 0000-0001-9962-9850

Observed ORCID: 0000-0001-9962-9850

OpenAlex ID: A5002856908

Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer

2019 · Devon R. Blake, Angelina V. Vaseva, et al. · Science Signaling · 71

Development of Novel IP6K Inhibitors for the Treatment of Obesity and Obesity-Induced Metabolic Dysfunctions

2022 · Yubai Zhou, Sandip Mukherjee, et al. · Journal of Medicinal Chemistry · 32

Discovery of Novel TYRO3/MERTK Dual Inhibitors

2025 · Deyu Kong, Jichen Zhao, et al. · Journal of Medicinal Chemistry · 5

Discovery of Novel 2-Substituted Aniline Pyrimidine Based Derivatives as Potent Mer/c-Met Dual Inhibitors with Improvement Bioavailability

2025 · Jixia Yang, Daowei Huang, et al. · Biomolecules · 2

Design, synthesis, and biological evaluation of novel potent dual Mer/c-Met inhibitors based on structural optimization

2025 · Lihong Duan, Xiaoyu Meng, et al. · Bioorganic & Medicinal Chemistry Letters · 1

Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer

2024 · Vaseva, Angelina V, Hodge, Richard G, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)

Works count: 6

Citation count: 111

H-index: 3

I10-index: 2